EF
Empirical Finance’s Quest Diagnostics DGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $734K | Buy |
4,086
+28
| +0.7% | +$5.03K | 0.04% | 364 |
|
|
2025
Q1 | $687K | Buy |
4,058
+154
| +4% | +$26.1K | 0.04% | 352 |
|
|
2024
Q4 | $589K | Sell |
3,904
-44
| -1% | -$6.64K | 0.03% | 377 |
|
|
2024
Q3 | $613K | Buy |
3,948
+76
| +2% | +$11.8K | 0.04% | 380 |
|
|
2024
Q2 | $530K | Sell |
3,872
-348
| -8% | -$47.6K | 0.03% | 396 |
|
|
2024
Q1 | $562K | Buy |
4,220
+133
| +3% | +$17.7K | 0.03% | 400 |
|
|
2023
Q4 | $564K | Buy |
4,087
+6
| +0.1% | +$827 | 0.04% | 376 |
|
|
2023
Q3 | $497K | Buy |
4,081
+306
| +8% | +$37.3K | 0.04% | 384 |
|
|
2023
Q2 | $531K | Buy |
3,775
+343
| +10% | +$48.2K | 0.04% | 350 |
|
|
2023
Q1 | $486K | Buy |
3,432
+146
| +4% | +$20.7K | 0.05% | 358 |
|
|
2022
Q4 | $514K | Buy |
3,286
+222
| +7% | +$34.7K | 0.05% | 325 |
|
|
2022
Q3 | $376K | Sell |
3,064
-2,825
| -48% | -$347K | 0.04% | 355 |
|
|
2022
Q2 | $783K | Sell |
5,889
-3,658
| -38% | -$486K | 0.1% | 188 |
|
|
2022
Q1 | $1.31M | Buy |
9,547
+245
| +3% | +$33.5K | 0.15% | 128 |
|
|
2021
Q4 | $1.61M | Sell |
9,302
-3,775
| -29% | -$653K | 0.19% | 98 |
|
|
2021
Q3 | $1.9M | Buy |
13,077
+4,377
| +50% | +$636K | 0.29% | 63 |
|
|
2021
Q2 | $1.15M | Buy |
+8,700
| New | +$1.15M | 0.19% | 113 |
|
|
2017
Q1 | – | Sell |
-217
| Closed | -$20K | – | 209 |
|
|
2016
Q4 | $20K | Buy |
+217
| New | +$20K | 0.01% | 200 |
|